Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
AMG-2674
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
AMP-PCP
Potential treatment - theoretical effect Experimental Antiviral Aug/03/2020
Anisomycin
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/02/2020
anti-IL-1α mAbs
Potential treatment - pre-clinical evidence Experimental Other treatment Jun/08/2020
Anti-SARS-CoV-2 monobody clone 6b
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/18/2020
Anti-spike nanobody-IFN-β conjugated exosomes
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2022
anti-spike-S1 IgYs
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/03/2020
AOaV-1-SARS-CoV-2
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/24/2020
Apabetalone
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/18/2021
Apicidin
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Apilimod
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020
Aptamer-1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Aptamer-2
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
AQ-13
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020
AR-12
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/20/2020
aRBD-2-5
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
aRBD-2-7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
ARCoV
Potential treatment - pre-clinical evidence Experimental Vaccine Jul/23/2020
AT-511
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
ATN-161
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020